Literature DB >> 2599466

A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study.

G Delgado1, B N Bundy, W C Fowler, F B Stehman, B Sevin, W T Creasman, F Major, P DiSaia, R Zaino.   

Abstract

Thirty-three institutions collaborating in the Gynecologic Oncology Group gathered surgical and pathological data on 1125 patients with primary, previously untreated, histologically confirmed stage I cervical carcinoma with more than 3 mm of invasion who were selected to undergo radical hysterectomy and paraaortic and pelvic lymphadenectomy. Of the 940 eligible, evaluable patients, 732 had squamous carcinoma. Of the study group, 87 (12%) did not undergo radical hysterectomy because of gross disease beyond the uterus or microscopic aortic node involvement documented at exploratory laparotomy. Among the 645 patients undergoing pelvic and paraaortic lymphadenectomy and radical hysterectomy, five risk factors were significantly associated with microscopic pelvic lymph node metastasis: depth of invasion (P = 0.0001), parametrial involvement (P = 0.0001), capillary-lymphatic space invasion (P = 0.0001), tumor grade (P = 0.01), and gross versus occult primary tumor (P = 0.009). The factors identified as independent risk factors for pelvic lymph node metastasis by multivariate analysis were capillary-lymphatic space involvement (P less than 0.0001), depth of invasion (P less than 0.0001), parametrial involvement (P = 0.0005), and age (P = 0.02). The model was used to predict the chance of a patient having nodal metastasis for any combination of risk factors.

Entities:  

Mesh:

Year:  1989        PMID: 2599466     DOI: 10.1016/0090-8258(89)90070-x

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  55 in total

1.  Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.

Authors:  Keiichiro Nakamura; Ikuo Joja; Junichi Kodama; Atsushi Hongo; Yuji Hiramatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

2.  Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer.

Authors:  Yong An Chung; Sung Hoon Kim; Hyung Sun Sohn; Soo Kyo Chung; Chae Chun Rhim; Sung Eun Namkoong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-22       Impact factor: 9.236

Review 3.  The role of imaging in the management of non-metastatic cervical cancer.

Authors:  Orit Kaidar-Person; Roxolyana Bortnyak-Abdah; Amnon Amit; Alison Berniger; Rahamim Ben-Yosef; Abraham Kuten
Journal:  Med Oncol       Date:  2012-04-25       Impact factor: 3.064

Review 4.  Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.

Authors:  Charles A Leath; Bradley J Monk
Journal:  Gynecol Oncol       Date:  2018-06-27       Impact factor: 5.482

Review 5.  The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.

Authors:  Maria Rosaria Raspollini; Sigurd F Lax; W Glenn McCluggage
Journal:  Virchows Arch       Date:  2018-05-24       Impact factor: 4.064

6.  Treatment outcomes and prognostic factors in uterine cervical cancer patients treated with postoperative extended field radiation therapy.

Authors:  Hak Jae Kim; Sung Whan Ha; Hong-Gyun Wu
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

Review 7.  Progress in the Study of Lymph Node Metastasis in Early-stage Cervical Cancer.

Authors:  Bang-Xing Huang; Fang Fang
Journal:  Curr Med Sci       Date:  2018-08-20

8.  A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.

Authors:  Juan Pu; Shan-shan Qin; Jin-xia Ding; Yan Zhang; Wei-guo Zhu; Chang-hua Yu; Tao Li; Guang-zhou Tao; Fu-zhi Ji; Xi-lei Zhou; Ji-hua Han; Ya-lin Ji; Jun-xia Sun
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-18       Impact factor: 4.553

9.  Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.

Authors:  Anuj Suri; Michael Frumovitz; Michael R Milam; Ricardo dos Reis; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2008-10-25       Impact factor: 5.482

10.  Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study.

Authors:  Matias Jurado; Rosendo Galván; Rafael Martinez-Monge; Jesús Mazaira; Juan Luis Alcazar
Journal:  World J Surg Oncol       Date:  2008-11-25       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.